C31H45N9O4
Neat
607.7
Bevemipretide; SBT-272; 2356106-71-1; F553HAL9V8; (2R)-2-amino-N-[(2S)-1-[[(1S)-5-amino-1-(3-benzyl-1, 2, 4-oxadiazol-5-yl)pentyl]amino]-3-(4-hydroxy-2, 6-dimethylphenyl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)pentanamide; (2R)-2-amino-N-((2S)-1-(((1S)-5-amino-1-(3-benzyl-1, 2, 4-oxadiazol-5-yl)pentyl)amino)-3-(4-hydroxy-2, 6-dimethylphenyl)-1-oxopropan-2-yl)-5-(diaminomethylideneamino)pentanamide; RefChem:1079734; (R)-2-amino-N-((S)-1-(((S)-5-amino-1-(3-benzyl-1, 2, 4-oxadiazol-5-yl)pentyl)amino)-3-(4-hydroxy-2, 6-dimethylphenyl)-1-oxopropan-2-yl)-5-guanidinopentanamide; L-Tyrosinamide, D-arginyl-N-[(1S)-5-amino-1-[3-(phenylmethyl)-1, 2, 4-oxadiazol-5-yl]pentyl]-2, 6-dimethyl-; bevemipretide [INN]; SBT272; SCHEMBL21062649; EX-A8193G; GTPL13258; DA-51080; HY-156600; CS-0885939; D-arginyl-N-[(1S)-5-amino-1-(3-benzyl-1, 2, 4-oxadiazol-5-yl)pentyl]-2 and 6-dimethyl-L-tyrosinamide
(2R)-2-amino-N-[(2S)-1-[[(1S)-5-amino-1-(3-benzyl-1, 2, 4-oxadiazol-5-yl)pentyl]amino]-3-(4-hydroxy-2 and 6-dimethylphenyl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)pentanamide
InChI=1S/C31H45N9O4/c1-19-15-22(41)16-20(2)23(19)18-26(38-28(42)24(33)11-8-14-36-31(34)35)29(43)37-25(12-6-7-13-32)30-39-27(40-44-30)17-21-9-4-3-5-10-21/h3-5,9-10,15-16,24-26,41H,6-8,11-14,17-18,32-33H2,1-2H3,(H,37,43)(H,38,42)(H4,34,35,36)/t24-,25+,26+/m1/s1